Philips shares fall 7% after U.S. drug regulator deals fresh blow to sleep device recall - CNBC
- Philips shares fall 7% after U.S. drug regulator deals fresh blow to sleep device recall CNBC
- US FDA still not satisfied with Philips recall; stock falls over 9% Reuters
- Philips Slumps After Another Blow to Its Sleep Product Recall Bloomberg
- Live news: Philips shares fall nearly 10% after FDA criticises product recall Financial Times
- Philips provides update on Respironics recall - News Philips
- View Full Coverage on Google News